# Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS

> **NCT07726940** · — · RECRUITING · sponsor: **Southeast University, China** · enrollment: 1776 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07726940
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-16
- **Primary completion:** 2030-01
- **Final completion:** 2030-02
- **Target enrollment:** 1776 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07726940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07726940, "Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07726940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*